Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

Abstract

The oral protease inhibitor nirmatrelvir is of key importance for prevention of severe coronavirus disease 2019 (COVID-19). To facilitate resistance monitoring, we studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from nirmatrelvir in cell culture. Resistant variants harbored combinations of substitutions in the SARS-CoV-2 main protease (Mpro). Reverse genetics revealed that E166V and L50F + E166V conferred high resistance in infectious culture, replicon, and Mpro systems. While L50F, E166V, and L50F + E166V decreased replication and Mpro activity, L50F and L50F + E166V variants had high fitness in the infectious system. Naturally occurring L50F compensated for fitness cost of E166V and promoted viral escape. Molecular dynamics simulations revealed that E166V and L50F + E166V weakened nirmatrelvir-Mpro binding. Polymerase inhibitor remdesivir and monoclonal antibody bebtelovimab retained activity against nirmatrelvir-resistant variants, and combination with nirmatrelvir enhanced treatment efficacy compared to individual compounds. These findings have implications for monitoring and ensuring treatments with efficacy against SARS-CoV-2 and emerging sarbecoviruses.

OriginalsprogEngelsk
Artikelnummereadd7197
TidsskriftScience Advances
Vol/bind8
Udgave nummer51
Sider (fra-til)eadd7197
DOI
StatusUdgivet - 21 dec. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system'. Sammen danner de et unikt fingeraftryk.

Citationsformater